← Back to Search

HIPEC for Bladder Cancer

N/A

Waitlist Available

Led By Douglas S Scherr, MD

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial is testing a new way to give chemotherapy to people with bladder cancer that has spread to their muscles. The study will look at how well the treatment works and if it has any side effects.

Eligible Conditions

Bladder Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Treatment toxicity

Trial Design

1Treatment groups

Experimental Treatment

Group I: HIPEC after Radical CystectomyExperimental Treatment1 Intervention

After completion of radical cystectomy, HIPEC will be administered using closed abdomen technique for a duration of 60 minutes.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HIPEC

2014

Completed Phase 3

~230

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor

1,059 Previous Clinical Trials

1,316,070 Total Patients Enrolled

Douglas S Scherr, MDPrincipal InvestigatorWeill Cornell Medicine - New York Presbyterian Hospital

2 Previous Clinical Trials

28 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric patients excluded from participation in this experiment?

"To be considered for this trial, potential participants must fit into the 45 to 85 age range. Notably, there are 7 registered trials available exclusively to individuals under 18 and 315 studies with a focus on geriatric care."

Answered by AI

Who is able to join this experiment?

"This clinical trial seeks 10 patients aged 45 to 85, who have been diagnosed with invasive bladder cancer. Additional eligibility criteria includes lymphovascular invasion in the background of primary urothelial (particularly plasmacytoid), an ECOG performance status < 1, ANC >1.5x109/L and platelets > 100x109/L as well as a negative pregnancy test for women of childbearing potential who are willing to use reliable contraception methods during their participation in this study. Furthermore, signed written consent is vital before any procedures can be initiated."

Answered by AI

Are there openings still available for potential participants in this investigation?

"According to clinicaltrials.gov, the enrollment period for this medical trial has elapsed; it was first uploaded on April 19th 2018 and last amended on August 22nd 2022. However, there are still 315 other trials that are actively in search of participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

2018. "HIPEC After Radical Cystectomy for High Risk Bladder Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03514888.